LCTX · Lineage Cell Therapeutics, Inc. · Documents
$1.00
+0.02 (+1.52%)
At close · Oct 23
View the 10-K filed Mar 5, 2026
Return incl. dividend (before tax)
Customer concentration
— top 2 customers 92% of revenue
2 customers — 92% of revenue (the year ended December 31, 2025)
“For the year ended December 31, 2025, the Company’s top two customers collectively represented 92% of the Company’s total revenue.”
One customer — 92% of revenue (the year ended December 31, 2024)
“For the year ended December 31, 2024, the Company's top single customer represented 92% of the Company’s total revenue.”
Market Cap
$252.91M
Shares
252.91M
Volume · Oct 23
1.15M
Avg daily vol (3M)
1.25M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2026-08-06 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| 8-K | — | 2026-06-12 | 2026-06-09 | |
| 10-Q | — | 2026-05-12 | 2026-03-31 | |
| 8-K | — | 2026-05-12 | — | |
| ARS | — | 2026-04-29 | 2025-12-31 | |
| DEFA14A | — | 2026-04-29 | — | |
| DEF 14A | — | 2026-04-29 | — | |
| S-3 | — | 2026-03-11 | — | |
| 8-K | — | 2026-03-11 | — | |
| 10-K | — | 2026-03-05 | 2025-12-31 | |
| 8-K | — | 2026-03-05 | — | |
| 8-K | — | 2025-11-28 | — | |
| 8-K | — | 2025-11-24 | 2025-11-20 | |
| 8-K | — | 2025-11-12 | — | |
| 8-K | — | 2025-11-06 | — | |
| 10-Q | — | 2025-11-06 | 2025-09-30 | |
| 8-K | — | 2025-08-26 | — | |
| 8-K | — | 2025-08-12 | — | |
| 10-Q | — | 2025-08-12 | 2025-06-30 | |
| 8-K | — | 2025-07-02 | 2025-06-26 | |
| 8-K | — | 2025-06-23 | — | |
| DEFA14A | — | 2025-06-11 | — | |
| 8-K | — | 2025-06-09 | 2025-06-03 | |
| 10-Q | — | 2025-05-13 | 2025-03-31 | |
| 8-K | — | 2025-05-13 | — | |
| 8-K | — | 2025-05-01 | — | |
| DEFA14A | — | 2025-04-29 | — | |
| ARS | — | 2025-04-29 | 2024-12-31 | |
| DEF 14A | — | 2025-04-29 | 2025-06-26 | |
| 8-K | — | 2025-03-10 | — | |
| 10-K | — | 2025-03-10 | 2024-12-31 | |
| 8-K | — | 2025-01-27 | — | |
| DEF 14A | — | 2024-12-09 | — | |
| PRE 14A | — | 2024-11-29 | — | |
| 8-K | — | 2024-11-20 | 2024-11-19 | |
| 8-K | — | 2024-11-14 | — | |
| 10-Q | — | 2024-11-14 | 2024-09-30 | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-08-08 | — | |
| 8-K | — | 2024-06-14 | 2024-06-11 | |
| 8-K | — | 2024-06-13 | 2024-06-11 | |
| 8-K | — | 2024-05-14 | — | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| DEFA14A | — | 2024-04-29 | — | |
| ARS | — | 2024-04-29 | — | |
| DEF 14A | — | 2024-04-29 | 2024-06-11 | |
| 8-K | — | 2024-03-22 | 2024-03-12 | |
| 10-K | — | 2024-03-07 | 2023-12-31 |
Showing 1–50 of 137 filings
Key facts
CIK
876343
CUSIP
53566P109
13F (30d)
26 filings
26 filers
Visit website
Investor relations